Oryzon Genomics S.A. (BME:ORY)
Spain · Delayed Price · Currency is EUR 2.902
0.00 (0.00%)
Jul 17, 2026, 5:35 PM CET
Oryzon Genomics Market Cap
Oryzon Genomics has a market cap or net worth of €237.84 million as of July 17, 2026. Its market cap has increased by 8.23% in one year.
Market Cap
237.84M
Enterprise Value
227.23M
Revenue
10.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.90
ChartMarket Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has increased from 122.00M to 237.84M, an increase of 94.95%. That is a compound annual growth rate of 6.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 237.84M | -3.01% |
| Dec 31, 2025 | 245.23M | 170.69% |
| Dec 31, 2024 | 90.60M | -16.71% |
| Dec 29, 2023 | 108.78M | -18.27% |
| Dec 30, 2022 | 133.08M | -6.58% |
| Dec 30, 2021 | 142.46M | -32.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.33B |
| Laboratorios Farmaceuticos Rovi | 2.74B |
| Almirall | 2.34B |
| Faes Farma | 1.35B |
| Clínica Baviera | 906.65M |
| Prim, S.A. | 226.28M |
| Laboratorio Reig Jofre | 215.74M |
| Atrys Health | 182.55M |